Catalyst Wire Dossier Catalyst Wire Dossier

OMontys

peginesatide · Affymax
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for OMontys, covering 2012-05-28 to 2013-06-28. Get the full timeline:

Most recent: EMA Application withdrawn: Omontys (peginesatide) — Takeda Global Research and Development Centre (Europe)

See pricing